| RS201603238 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysosomal acid lipase deficiency, Wolman disease |
| RS201603256 |
CHRNA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy, Inborn genetic diseases |
| RS201603384 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS201603580 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS201603899 |
TUBB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201604061 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with autism and macrocephaly, Inborn genetic diseases |
| RS201604102 |
BTD
|
Health Risk |
Pathogenic/Likely pathogenic |
Biotinidase deficiency, Inborn genetic diseases |
| RS201604273 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS201604337 |
SLC6A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperekplexia 3, Inborn genetic diseases |
| RS201604887 |
SCN1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Migraine, familial hemiplegic |
| RS201605109 |
ADAMTS14
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201605273 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS201605296 |
SALL2
|
Health Risk |
Conflicting classifications of pathogenicity |
SALL2-related disorder, SALL2-related disorder |
| RS201605347 |
C2CD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201605414 |
ALDH4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS201605654 |
ZAP70
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS201606169 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS201606177 |
COL4A1
|
Health Risk |
Likely pathogenic |
Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome, Hemorrhage |
| RS201606213 |
INTS1
|
Health Risk |
Conflicting classifications of pathogenicity |
INTS1-related disorder, INTS1-related disorder |
| RS201606637 |
WWOX
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive spinocerebellar ataxia 12, Developmental and epileptic encephalopathy |
| RS201607115 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal dominant Alport syndrome |
| RS201607149 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS201607271 |
EARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome, Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome |
| RS201607490 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS201607698 |
WDPCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 15, Bardet-Biedl syndrome |
| RS201607834 |
CNTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Compton-North congenital myopathy, Inborn genetic diseases |
| RS201607866 |
TRIP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IA |
| RS201607912 |
FAM222B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201607999 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2016082493 |
IGF1R
|
Health Risk |
Pathogenic |
— |
| RS201608372 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated Nonsyndromic Congenital Heart Disease, Alagille syndrome due to a JAG1 point mutation |
| RS201608609 |
SLC12A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Kilquist syndrome, Hearing loss |
| RS201608921 |
SLC26A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrolithiasis, calcium oxalate |
| RS201609001 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS201609436 |
GPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201609442 |
NSD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Sotos syndrome, Sotos syndrome |
| RS201609461 |
IFNAR1
|
Health Risk |
Pathogenic |
Immunodeficiency 106, susceptibility to viral infections |
| RS201610096 |
CDH23
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1D, Autosomal recessive nonsyndromic hearing loss 12 |
| RS201610494 |
BDP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201610567 |
VCP
|
Health Risk |
Conflicting classifications of pathogenicity |
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia, Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 |
| RS201610681 |
ATP13A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS201610682 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS201611215 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Inborn genetic diseases |
| RS201611359 |
SLC4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
11 conditions, Inborn genetic diseases |
| RS201611496 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS201611688 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS201611946 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS201612257 |
CACNA1A
|
Health Risk |
Pathogenic |
— |
| RS201612374 |
LHX4
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature-pituitary and cerebellar defects-small sella turcica syndrome, Inborn genetic diseases |
| RS201613240 |
OTOF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS201613456 |
RAB3GAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Warburg micro syndrome 2, Martsolf syndrome |
| RS201613668 |
TPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 2, Autosomal recessive spinocerebellar ataxia 7 |
| RS201613702 |
CPAMD8
|
Health Risk |
Conflicting classifications of pathogenicity |
CPAMD8-related disorder, Inborn genetic diseases |
| RS201613746 |
SKI
|
Health Risk |
Conflicting classifications of pathogenicity |
Shprintzen-Goldberg syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS201613747 |
PLOD3
|
Health Risk |
Pathogenic |
— |
| RS201613780 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS201613894 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Connective tissue disorder |
| RS201614038 |
NFKBIA
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectodermal dysplasia and immunodeficiency 2, Ectodermal dysplasia and immunodeficiency 2 |
| RS201614105 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS201614191 |
PDGFRA
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS201614215 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 4 |
| RS201614312 |
TNNI3K
|
Health Risk |
Conflicting classifications of pathogenicity |
TNNI3K-related disorder, TNNI3K-related disorder |
| RS201614446 |
QRSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201614524 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Myopathy, myofibrillar |
| RS201614853 |
BCKDK
|
Health Risk |
Conflicting classifications of pathogenicity |
Branched-chain keto acid dehydrogenase kinase deficiency, Branched-chain keto acid dehydrogenase kinase deficiency |
| RS201615111 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal recessive Alport syndrome |
| RS201615354 |
CLN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS201615847 |
FBXL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 13, Mitochondrial DNA depletion syndrome 13 |
| RS201615936 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS201615997 |
LEMD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201616111 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201616211 |
GOSR2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy type 6, Muscular dystrophy |
| RS201616704 |
CHAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial infantile myasthenia, Familial infantile myasthenia |
| RS201616934 |
NEFL
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2E, Charcot-Marie-Tooth disease type 2E |
| RS201616962 |
DVL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201617124 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS201617246 |
NUP93
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 12 |
| RS201617511 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculotrichoanal syndrome, Trigonocephaly 2 |
| RS201617644 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS201617661 |
PCARE
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS201617723 |
SLC3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystinuria, Cystinuria |
| RS201617759 |
TRPM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1C, Retinal dystrophy |
| RS201617914 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS201618350 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS201618718 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS201618750 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS201618854 |
TBC1D24
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 1 |
| RS201618995 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS201619005 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS201619500 |
MKS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 1 |
| RS201619538 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Autoinflammatory syndrome |
| RS201619646 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS201619712 |
NSD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201619737 |
IARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome, Inborn genetic diseases |
| RS201619743 |
CFB
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome with B factor anomaly, Macular degeneration |
| RS201619917 |
SLC4A11
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS201620100 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS201620155 |
AP5Z1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 48, Hereditary spastic paraplegia 48 |
| RS201620358 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Connective tissue disorder |
| RS201620629 |
TBX6
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondylocostal dysostosis 5, Spondylocostal dysostosis 5 |